Filter announcements
Loading...
Incorporated in 1993, Omkar Specialty Chemicals Ltd is engaged in the manufacture and sale of Specialty Chemicals and Pharma Intermediates for Chemical and Allied Industries.
Omkar Speciality Chemicals has announced a board meeting to approve pending financial results from FY2022 to FY2025. This follows past Corporate Insolvency Resolution Process. Trading in its shares remains suspended.
Omkar Speciality Chemicals' Board approved the sale of two industrial plots in Badlapur. This asset rationalization move aims to streamline operations or potentially boost cash reserves for the company.
OMKARCHEM's Monitoring Committee has announced a meeting on May 27, 2026. Agenda includes approving multiple quarterly financial results, appointing a CEO, Independent Director, and auditors, constituting committees, and discussing CIRP costs.
Omkar Speciality Chemicals' existing shares will be reduced to zero. A Resolution Applicant will acquire 100% ownership via new share issuance. An Offer for Sale of 5% will then occur to meet public shareholding norms. Significant restructuring ahead.